Advertisement

Roles of folate in skeletal muscle cell development and functions

  • Seong Yeon Hwang
  • Bokyung Sung
  • Nam Deuk KimEmail author
Review
  • 132 Downloads

Abstract

Folate is the generic term for both naturally occurring food folate and folic acid, the fully oxidized monoglutamate form of the vitamin that is used in dietary supplements and fortified foods. It is a water-soluble vitamin B9 and is important for health, growth, and development. As a precursor of various cofactors, folate is required for one-carbon donors in the synthesis of DNA bases and other essential biomolecules. A lack of dietary folate can lead to folate deficiency and can therefore result in several health problems, including macrocytic anemia, elevated plasma homocysteine, cardiovascular disease, birth defects, carcinogenesis, muscle weakness, and difficulty in walking. Several studies have implied that folate might exert a positive effect on skeletal muscle development. However, the precise effects of folate in skeletal muscle development are still poorly understood. Thus, this review provides an updated discussion of the roles of folate in skeletal muscle cell development and the effects of folic acid supplementation on the functions of skeletal muscle cells.

Keywords

Folate Folic acid Supplementation C2C12 cells Differentiation Akt Sarcopenia 

Notes

Acknowledgements

This work was supported by a 2-Year Research Grant of Pusan National University.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. Anker SD, Morley JE, Von Haehling S (2016) Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7:512–514CrossRefGoogle Scholar
  2. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Philips S, Sieber P, Teta D, Visvanathan R, Volpi E, Boirie Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14:542–559CrossRefGoogle Scholar
  3. Blackwell TK, Weintraub H (1990) Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104–1110CrossRefGoogle Scholar
  4. Blom HJ, Smulders Y (2011) Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 34:75–81CrossRefGoogle Scholar
  5. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K, NORVIT Trial Investigators (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 254:1578–1588CrossRefGoogle Scholar
  6. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA, Tapscott SJ (2006) Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J 25:502–511CrossRefGoogle Scholar
  7. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, Macquarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ (2010) Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 18:662–674CrossRefGoogle Scholar
  8. Carmel R (2005) Folic acid. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ (eds) Modern nutrition in health and disease, 10th edn. Lippincott Williams & Wilkins, Philadelphia, pp 470–481Google Scholar
  9. Carrio E, Suelves M (2015) DNA methylation dynamics in muscle development and disease. Front Aging Neurosci 7:19CrossRefGoogle Scholar
  10. Chanarin I (1979) The megaloblastic anaemias. Blackwell Scientific Publications, OxfordGoogle Scholar
  11. Clarke R, Grimley Evans J, Schneede J, Nexo E, Bates C, Fletcher A, Prentice A, Johnston C, Ueland PM, Refsum H, Sherliker P, Birks J, Whitlock G, Breeze E, Scott JM (2004) Vitamin B12 and folate deficiency in later life. Age Ageing 33:34–41CrossRefGoogle Scholar
  12. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, Mckeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER, Polyp Prevention Study Group (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297:2351–2359CrossRefGoogle Scholar
  13. Cuskelly GJ, Mooney KM, Young IS (2007) Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 66:548–558CrossRefGoogle Scholar
  14. Czeizel AE, Dudas I, Vereczkey A, Banhidy F (2013) Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients 5:4760–4775CrossRefGoogle Scholar
  15. De Ocampo MPG, Araneta MRG, Macera CA, Alcaraz JE, Moore TR, Chambers CD (2018) Folic acid supplement use and the risk of gestational hypertension and preeclampsia. Women Birth 31:e77–e83CrossRefGoogle Scholar
  16. Deniz BF, Confortim HD, Deckmann I, Miguel PM, Bronauth L, De Oliveira BC, Barbosa S, Cechinel LR, Siqueira IR, Pereira LO (2018) Folic acid supplementation during pregnancy prevents cognitive impairments and BDNF imbalance in the hippocampus of the offspring after neonatal hypoxia-ischemia. J Nutr Biochem 60:35–46CrossRefGoogle Scholar
  17. Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Bestphal A, Cederholm T, Cruz-Jentoft A, Krznaric Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33:929–936CrossRefGoogle Scholar
  18. Elsborg L, Larsen L (1979) Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 14:1019–1024PubMedGoogle Scholar
  19. Halimi Asl AA, Safari S, Parvareshi Hamrah M (2017) Epidemiology and related risk factors of preterm labor as an obstetrics emergency. Emerg (Tehran) 5:e3Google Scholar
  20. Hwang SY, Kang YJ, Sung B, Kim M, Kim DH, Lee Y, Yoo MA, Kim CM, Chung HY, Kim ND (2015) Folic acid promotes the myogenic differentiation of C2C12 murine myoblasts through the Akt signaling pathway. Int J Mol Med 36:1073–1080CrossRefGoogle Scholar
  21. Hwang SY, Kang YJ, Sung B, Jang JY, Hwang NL, Oh HJ, Ahn YR, Kim HJ, Shin JH, Yoo MA, Kim CM, Chung HY, Kim ND (2018) Folic acid is necessary for proliferation and differentiation of C2C12 myoblasts. J Cell Physiol 233:736–747CrossRefGoogle Scholar
  22. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9CrossRefGoogle Scholar
  23. Jang YJ, Son HJ, Kim JS, Jung CH, Ahn J, Hur J, Ha TY (2018) Coffee consumption promotes skeletal muscle hypertrophy and myoblast differentiation. Food Funct 9:1102–1111CrossRefGoogle Scholar
  24. Jiang BH, Aoki M, Zheng JZ, Li J, Vogt PK (1999) Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA 96:2077–2081CrossRefGoogle Scholar
  25. Kelly OJ, Gilman JC, Kim Y, Ilich JZ (2016) Micronutrient intake in the etiology, prevention and treatment of osteosarcopenic obesity. Curr Aging Sci 9:260–278CrossRefGoogle Scholar
  26. Kilsby AJ, Sayer AA, Witham MD (2017) Selecting potential pharmacological interventions in sarcopenia. Drugs Aging 34:233–240CrossRefGoogle Scholar
  27. Kim YI, Pogribny IP, Basnakian AG, Miller JW, Selhub J, James SJ, Mason JB (1997) Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr 65:46–52CrossRefGoogle Scholar
  28. Kim J, Kim H, Roh H, Kwon Y (2018) Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res 41:372–383CrossRefGoogle Scholar
  29. Li Y, Zhang X, Sun Y, Feng Q, Li G, Wang M, Cui X, Kang L, Jiang Y (2013) Folate deficiency during early-mid pregnancy affects the skeletal muscle transcriptome of piglets from a reciprocal cross. PLoS ONE 8:e82616CrossRefGoogle Scholar
  30. Li H, Xu W, Ma Y, Zhou S, Xiao R (2018a) Milk fat globule membrane protein promotes C2C12 cell proliferation through the PI3 K/Akt signaling pathway. Int J Biol Macromol 114:1305–1314CrossRefGoogle Scholar
  31. Li Y, Feng Q, Guo M, Wang Y, Jiang Y, Xing J (2018b) Genome-wide survey reveals dynamic effects of folate supplement on DNA methylation and gene expression during C2C12 differentiation. Physiol Genomics 50:158–168CrossRefGoogle Scholar
  32. Linhart HG, Troen A, Bell GW, Cantu E, Chao WH, Moran E, Steine E, He T, Jaenisch R (2009) Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations. Gastroenterology 136(227–235):e223Google Scholar
  33. Mangner N, Adams V, Sandri M, Hoellriegel R, Hambrecht R, Schuler G, Gielen S (2012) Muscle function and running activity in mouse models of hereditary muscle dystrophy: impact of double knockout for dystrophin and the transcription factor MyoD. Muscle Nerve 45:544–551CrossRefGoogle Scholar
  34. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493–495CrossRefGoogle Scholar
  35. McGlory C, van Vliet S, Stokes T, Mitendorfer B, Phillips SM (2018) The impact of exercise and nutrition on the regulation of skeletal muscle mass. J Physiol.  https://doi.org/10.1113/JP275443 CrossRefPubMedGoogle Scholar
  36. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J (1994) Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine’s co-ordinate regulation of homocysteine metabolism. Biochem J 298(Pt 2):415–419CrossRefGoogle Scholar
  37. Miyata K, Miyata T, Nakabayashi K, Okamura K, Naito M, Kawai T, Takada S, Kato K, Miyamoto S, Hata K, Asahara H (2015) DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation. Hum Mol Genet 24:410–423CrossRefGoogle Scholar
  38. Moat SJ, Lang D, Mcdowell IF, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J (2004) Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15:64–79CrossRefGoogle Scholar
  39. Molloy AM, Pangilinan F, Brody LC (2017) Genetic risk factors for folate-responsive neural tube defects. Annu Rev Nutr 37:269–291CrossRefGoogle Scholar
  40. Okumura K, Tsukamoto H (2011) Folate in smokers. Clin Chim Acta 412:521–526CrossRefGoogle Scholar
  41. Oster M, Trakooljul N, Reyer H, Zeyner A, Murani E, Ponsuksili S, Wimmers K (2017) Sex-specific muscular maturation responses following prenatal exposure to methylation-related micronutrients in pigs. Nutrients 9:74CrossRefGoogle Scholar
  42. Patanwala I, King MJ, Barrett DA, Rose J, Jackson R, Hudson M, Philo M, Dainty JR, Wright AJ, Finglas PM, Jones DE (2014) Folic acid handling by the human gut: implications for food fortification and supplementation. Am J Clin Nutr 100:593–599CrossRefGoogle Scholar
  43. Pena J, Claro JC (2014) Is folic acid effective for the prevention of cardiovascular events in patients with advanced or terminal chronic kidney disease? Rev Med Chil 142:636–645CrossRefGoogle Scholar
  44. Phillips SM (2015) Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr 6:452–460CrossRefGoogle Scholar
  45. Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, Bischoff-Ferrari H, Bruyère O, Cesari M, Dawson-Hughes B, Fielding RA, Kaufman JM, Landi F, Malafarina V, Rolland Y, van Loon LJ, Vellas B, Visser M, Cooper C, ESCEO working group (2018) Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr 37:1121–1132CrossRefGoogle Scholar
  46. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009–1013CrossRefGoogle Scholar
  47. Sassoli C, Vallone L, Tani A, Chellini F, Nosi D, Zecchi-Orlandini S (2018) Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration. Cell Tissue Res 372:549–570CrossRefGoogle Scholar
  48. Shane B (1995) Folate chemistry and metabolism. In: Bailey LB (ed) Folate in health and disease. Marcel Dekker Inc, New York, pp 1–22Google Scholar
  49. Stam F, Smulders YM, Van Guldener C, Jakobs C, Stehouwer CD, De Meer K (2005) Folic acid treatment increases homocysteine remethylation and methionine transmethylation in healthy subjects. Clin Sci (Lond) 108:449–456CrossRefGoogle Scholar
  50. Sumitani S, Goya K, Testa JR, Kouhara H, Kasayama S (2002) Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology 143:820–828CrossRefGoogle Scholar
  51. Swart KM, Enneman AW, Van Wijngaarden JP, Van Dijk SC, Brouwer-Brolsma EM, Ham AC, Dhonukshe-Rutten RA, Van Der Velde N, Brug J, Van Meurs JB, De Groot LC, Uitterlinden AG, Lips P, Van Schoor NM (2013) Homocysteine and the methylenetetrahydrofolate reductase 677C → T polymorphism in relation to muscle mass and strength, physical performance and postural sway. Eur J Clin Nutr 67:743–748CrossRefGoogle Scholar
  52. Tajbakhsh S (2009) Skeletal muscle stem cells in developmental versus regenerative myogenesis. J Intern Med 266:372–389CrossRefGoogle Scholar
  53. Tamaki M, Miyashita K, Haqiwara A, Wakino S, Inoue H, Fujiii K, Fujii C, Endo S, Uto A, Mitsuishi M, Sata M, Doi T, Itoh H (2017) Ghrelin treatment improves physical decline in sarcopenia model mice through muscular enhancement and mitochondrial activation. Endocr J 64:S47–S51CrossRefGoogle Scholar
  54. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120:11–19CrossRefGoogle Scholar
  55. Tessier AJ, Chevalier S (2018) An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients.  https://doi.org/10.3390/nu10081099 CrossRefPubMedPubMedCentralGoogle Scholar
  56. Tsumagari K, Baribault C, Terragni J, Varley KE, Gertz J, Pradhan S, Badoo M, Crain CM, Song L, Crawford GE, Myers RM, Lacey M, Ehrlich M (2013) Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics 8:317–332CrossRefGoogle Scholar
  57. van Dijk M, Dijk FJ, Hartoq A, van Norren K, Verlaan S, van Helvoort A, Jaspers RT, Luiking Y (2018) Reduced dietary intake of micronutrients with antioxidant properties negatively impacts muscle health in aged mice. J Cachexia Sarcopenia Muscle 9:146–159CrossRefGoogle Scholar
  58. Veeranki S, Winchester LJ, Tyagi SC (2015) Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications. Biochim Biophys Acta 1852:732–741CrossRefGoogle Scholar
  59. Wakabayashi H, Sakuma K (2014) Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol 9:171–180CrossRefGoogle Scholar
  60. Wee AK (2016) Serum folate predicts muscle strength: a pilot cross-sectional study of the association between serum vitamin levels and muscle strength and gait measures in patients > 65 years old with diabetes mellitus in a primary care setting. Nutr J 15:89CrossRefGoogle Scholar
  61. Wu A, Chanarin I, Slavin G, Levi AJ (1975) Folate deficiency in the alcoholic—its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br J Haematol 29:469–478CrossRefGoogle Scholar
  62. Wu H, Xia Y, Jiang J, Du H, Guo X, Liu X, Li C, Huang G, Niu K (2015) Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr 61:168–175CrossRefGoogle Scholar
  63. Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725–727CrossRefGoogle Scholar
  64. Yarasheski KE (2003) Exercise, aging, and muscle protein metabolism. Gerontol A Biol Sci Med Sci 58:M918–M922CrossRefGoogle Scholar
  65. Yuan Z, Chen Y, Zhang X, Zhou X, Li M, Chen H, Wu M, Zhang Y, Mo D (2017) Silencing myotubularin related protein 7 enhances proliferation and early differentiation of C2C12 myoblast. Biochem Biophys Res Commun 484:592–597CrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2019

Authors and Affiliations

  1. 1.Department of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, College of PharmacyPusan National UniversityBusanRepublic of Korea

Personalised recommendations